CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-27
DOI: 10.2147/dddt.s650566 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Tingting Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, Carcinoembryonic Antigen, Molecular Targeted Therapy, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China.
- The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, 341000, People's Republic of China.
Zitieren
APA
Ye, T., Mei, R., Liu, X., & Huang, P. (2026). CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies. Drug Design, Development and Therapy, Volume 20, 1-27. https://doi.org/10.2147/dddt.s650566
Vancouver
Ye T, Mei R, Liu X, Huang P. CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies. Drug Design, Development and Therapy. 2026;Volume 20:1-27. doi:10.2147/dddt.s650566
BibTeX
@article{Ye2026,
author = {Ye, Tingting and Mei, Ruohan and Liu, Xiaoting and Huang, Panpan},
title = {CEACAM5-Targeted Therapies in Solid Tumors: Biological Barriers and Next-Generation Precision Strategies},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--27},
doi = {10.2147/dddt.s650566}
}
EUVIMED